Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Gene Therapy|February 12, 1998
Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor modelsT Tüting, A Gambotto, J Baar, et al.
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Annals of Internal Medicine|September 1, 1987
The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cellsK D Denicoff, D R Rubinow, M Z Papa, et al.
International Journal of Cancer|October 1, 1998
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasmsH Okada, H Tahara, M R Shurin, et al.
Human Pathology|May 1, 1990
Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patientsA H Kragel, W D Travis, L Feinberg, et al.
The Cancer Journal From Scientific American|February 11, 1998
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapyM T Lotze, B Hellerstedt, L Stolinski, et al.
The Journal of Experimental Medicine|April 1, 1996
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccinesJ I Mayordomo, D J Loftus, H Sakamoto, et al.
Oncogene|January 16, 2013
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergeticsR Kang, D Tang, N E Schapiro, et al.
Cellular Immunology|November 1, 1996
Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4P M Mertz, M L Corcoran, K M McCluskey, et al.
Cellular Immunology|August 1, 1997
FLT3 ligand induces the generation of functionally active dendritic cells in miceM R Shurin, P P Pandharipande, T D Zorina, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Gene Therapy|February 12, 1998
Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor modelsT Tüting, A Gambotto, J Baar, et al.
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Annals of Internal Medicine|September 1, 1987
The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cellsK D Denicoff, D R Rubinow, M Z Papa, et al.
International Journal of Cancer|October 1, 1998
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasmsH Okada, H Tahara, M R Shurin, et al.
Human Pathology|May 1, 1990
Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patientsA H Kragel, W D Travis, L Feinberg, et al.
The Cancer Journal From Scientific American|February 11, 1998
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapyM T Lotze, B Hellerstedt, L Stolinski, et al.
The Journal of Experimental Medicine|April 1, 1996
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccinesJ I Mayordomo, D J Loftus, H Sakamoto, et al.
Oncogene|January 16, 2013
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergeticsR Kang, D Tang, N E Schapiro, et al.
Cellular Immunology|November 1, 1996
Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4P M Mertz, M L Corcoran, K M McCluskey, et al.
Cellular Immunology|August 1, 1997
FLT3 ligand induces the generation of functionally active dendritic cells in miceM R Shurin, P P Pandharipande, T D Zorina, et al.
Pageof 25